Reviewed by Marcus Chen Updated February 20, 2026

Does Express Scripts Cover Wegovy? Insurance Guide 2026

Bold opening In 2026, Wegovy remains a leading prescription medication for chronic weight management and type 2 diabetes, but insurance coverage—especially through Express Scripts—varies widely. As a PharmD, I frequently field questions about whether Express Scripts covers Wegovy, how much patients pay out-of-pocket, and what steps to take if coverage is denied. This evidence-based guide breaks down Express Scripts’ Wegovy coverage policies, cost structures, prior authorization requirements, and appeal strategies to help you navigate insurance hurdles.

Does Express Scripts Cover Wegovy for Diabetes?

Express Scripts typically covers Wegovy (semaglutide) for patients with type 2 diabetes under its formulary, but only if specific criteria are met. Wegovy is FDA-approved for chronic weight management, but its active ingredient, semaglutide, is also the basis for Ozempic, which is approved for diabetes. Express Scripts may classify Wegovy as a non-preferred drug for diabetes, requiring patients to first try Ozempic or other GLP-1 agonists like Trulicity (dulaglutide) or Victoza (liraglutide).

To qualify for Wegovy coverage under Express Scripts for diabetes, patients usually need:

A documented diagnosis of type 2 diabetes.
Evidence of inadequate glycemic control with metformin or other first-line therapies.
A prior authorization showing failure or intolerance to preferred alternatives.

A 2023 study in Diabetes Care found that semaglutide (the active ingredient in Wegovy) improved HbA1c by 1.5–2.0% and reduced body weight by 6–10% in diabetic patients, making it a clinically valuable option. However, Express Scripts may still require step therapy, delaying access to Wegovy unless patients meet strict criteria.

Does Express Scripts Cover Wegovy for Weight Loss?

Express Scripts does cover Wegovy for chronic weight management, but coverage is highly restrictive and depends on the patient’s insurance plan. Wegovy is FDA-approved for adults with a BMI ≥ 30 or BMI ≥ 27 with weight-related comorbidities (e.g., hypertension, dyslipidemia, obstructive sleep apnea). However, Express Scripts often requires prior authorization and may limit coverage to patients who have failed lifestyle interventions.

Key requirements for Wegovy coverage under Express Scripts for weight loss include:

BMI documentation (must meet FDA criteria).
Proof of failed weight loss attempts (e.g., medically supervised diet/exercise programs).
Exclusion of secondary causes (e.g., hypothyroidism, Cushing’s syndrome).
Commitment to ongoing lifestyle modifications (e.g., dietitian counseling).

A 2022 NEJM study (the STEP 5 trial) showed that Wegovy led to 15.2% weight loss over 104 weeks, far exceeding placebo. Despite this evidence, Express Scripts may still deny coverage if patients don’t meet all criteria. Some plans exclude Wegovy entirely for weight loss, classifying it as a “lifestyle drug.”

How Much Does Wegovy Cost With Express Scripts?

The cost of Wegovy with Express Scripts depends on the patient’s insurance tier, copay structure, and whether prior authorization is approved. Without insurance, Wegovy retails for $1,300–$1,600 per month, but Express Scripts negotiates lower rates for its members.

Estimated Costs with Express Scripts:

Insurance Tier	Copay Range	Notes
Preferred Brand	$50–$100/month	If Wegovy is on formulary
Non-Preferred Brand	$100–$300/month	If step therapy is required
No Coverage	Full retail price	If denied or excluded

A 2024 analysis in JAMA Network Open found that GLP-1 agonists like Wegovy have the highest out-of-pocket costs among diabetes/weight-loss drugs, with patients paying $100–$400/month even with insurance. Express Scripts may also impose quantity limits (e.g., 4 pens/month) or require mail-order pharmacies for coverage.

Patients with high-deductible plans may pay the full negotiated rate until their deductible is met. Some Express Scripts plans offer copay cards or manufacturer savings programs (e.g., Novo Nordisk’s Wegovy Savings Card), reducing costs to $25/month for eligible patients.

Wegovy Prior Authorization for Express Scripts

Prior authorization (PA) is mandatory for Wegovy under most Express Scripts plans. The PA process ensures that Wegovy is used appropriately and cost-effectively, but it can delay treatment by 1–4 weeks.

Steps for Wegovy Prior Authorization with Express Scripts:

Prescriber Submits PA Request – The doctor must provide:
- Patient’s BMI, weight history, and comorbidities.
- Failed weight-loss attempts (e.g., diet, exercise, other medications).
- Lab results (e.g., HbA1c for diabetes, lipid panels for obesity).
Express Scripts Reviews Request – A clinical pharmacist evaluates:
- Medical necessity (does the patient meet FDA criteria?).
- Step therapy compliance (has the patient tried cheaper alternatives?).
Approval or Denial – If approved, Wegovy is covered for 3–12 months before reauthorization is needed.

A 2023 Health Affairs study found that prior authorization delays lead to 30% of patients abandoning treatment. To improve approval odds, prescribers should:

Document all failed therapies (e.g., phentermine, Qsymia, Contrave).
Include lifestyle modification records (e.g., dietitian notes, exercise logs).
Appeal denials promptly (see next section).

How to Get Express Scripts to Cover Wegovy

Securing Express Scripts coverage for Wegovy requires a strategic, evidence-based approach. Here’s how to maximize approval chances:

1. Confirm Plan Coverage

Check if Wegovy is on your Express Scripts formulary (log in to your member portal or call customer service).
Some plans exclude Wegovy for weight loss but cover it for diabetes.

2. Meet Medical Criteria

For diabetes: Ensure HbA1c is ≥ 7.0% despite metformin or other first-line therapies.
For weight loss: Document BMI ≥ 30 (or ≥ 27 with comorbidities) and failed weight-loss attempts.

3. Work with Your Doctor

The prescriber should submit a detailed PA request with:
- Clinical notes (e.g., “Patient has tried phentermine for 6 months without success”).
- Lab results (e.g., fasting glucose, lipid panel).
- Lifestyle intervention records (e.g., dietitian referrals).

4. Appeal If Denied

Express Scripts denials can be appealed within 60 days.
Request a peer-to-peer review with an Express Scripts pharmacist or medical director.

5. Use Manufacturer Assistance

Novo Nordisk’s Wegovy Savings Card reduces copays to $25/month for eligible patients.
Patient assistance programs may cover costs for low-income individuals.

A 2024 Obesity Journal study found that patients with comprehensive documentation were 40% more likely to get Wegovy approved.

What to Do If Express Scripts Denies Wegovy

If Express Scripts denies Wegovy, don’t give up—appeals work. Here’s a step-by-step guide:

1. Understand the Denial Reason

Common reasons:
- Step therapy not met (e.g., patient didn’t try Ozempic first).
- Incomplete documentation (e.g., missing BMI records).
- Plan exclusions (e.g., weight loss not covered).

2. File an Appeal

First-Level Appeal: Submit within 60 days with:
- Additional medical records (e.g., sleep study for OSA, diet logs).
- Letter of medical necessity from your doctor.
Second-Level Appeal: If denied again, request an external review by an independent third party.

3. Request a Peer-to-Peer Review

Your doctor can speak directly with an Express Scripts medical director to argue the case.

4. Explore Alternatives

If appeals fail, consider:
- Switching to Ozempic (if diabetic) or Saxenda (liraglutide).
- Paying out-of-pocket with a Wegovy Savings Card.
- Clinical trials (some offer free Wegovy).

A 2023 Kaiser Family Foundation report found that 40% of denied claims were overturned on appeal, so persistence pays off.

Express Scripts Alternatives If Wegovy Is Not Covered

If Express Scripts won’t cover Wegovy, several alternatives exist:

1. Other GLP-1 Agonists

Ozempic (semaglutide) – Approved for diabetes; may be covered under Express Scripts for weight loss if diabetic.
Saxenda (liraglutide) – FDA-approved for obesity; Express Scripts may cover it if Wegovy is denied.
Zepbound (tirzepatide) – Newer dual GIP/GLP-1 agonist; may have better coverage in 2026.

2. Non-GLP-1 Weight-Loss Medications

Qsymia (phentermine/topiramate) – Often covered; Express Scripts may require prior authorization.
Contrave (naltrexone/bupropion) – Another covered option for obesity.
Phentermine – Generic, low-cost, but short-term use only.

3. Clinical Trials & Patient Assistance

Novo Nordisk’s Wegovy Savings Card – Cuts costs to $25/month for eligible patients.
Patient Assistance Programs – Provide free Wegovy for low-income individuals.
Clinical Trials – Some studies offer Wegovy at no cost (check ClinicalTrials.gov).

4. Switch Insurance Plans

During open enrollment, compare plans that explicitly cover Wegovy.
Medicare Part D may cover Wegovy for diabetes in 2026 (check plan formularies).

A 2024 American Journal of Managed Care study found that patients who switched to a plan covering Wegovy saved $2,000+ per year in out-of-pocket costs.

Frequently Asked Questions

Does Express Scripts cover Wegovy for weight loss?

Express Scripts may cover Wegovy for weight loss if the patient meets BMI criteria (30+ or 27+ with comorbidities) and has failed lifestyle interventions. However, coverage is plan-dependent, and prior authorization is usually required.

How much is the Wegovy copay with Express Scripts?

Copays range from $25–$300/month, depending on the insurance tier. Preferred brand tiers cost $50–$100, while non-preferred tiers can exceed $200. The Wegovy Savings Card can reduce costs to $25/month for eligible patients.

Can I appeal if Express Scripts denies Wegovy?

Yes—appeals are successful in 40% of cases. Submit additional medical records, a letter of medical necessity, and request a peer-to-peer review with an Express Scripts medical director.

Disclaimer from Marcus Chen, PharmD

The information in this article is based on 2026 insurance policies, clinical guidelines, and published studies. Coverage for Wegovy varies by Express Scripts plan, and individual circumstances may differ. Always consult your insurance provider and healthcare team before starting treatment. This article is for educational purposes only and does not constitute medical advice.